相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tau PET imaging with 18F-PI-2620 in aging and neurodegenerative diseases
Elizabeth C. Mormino et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Tau-positron emission tomography correlates with neuropathology findings
Val J. Lowe et al.
ALZHEIMERS & DEMENTIA (2020)
Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948
Ruben Smith et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Evaluation of Dosimetry, Quantitative Methods, and Test-Retest Variability of 18F-PI-2620 PET for the Assessment of Tau Deposits in the Human Brain
Santiago Bullich et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age
Tobey J. Betthauser et al.
BRAIN (2020)
Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET
Renaud La Joie et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease
Rik Ossenkoppele et al.
JAMA NEUROLOGY (2020)
Tau PET Imaging with [18F]PM-PBB3 in Frontotemporal Dementia with MAPT Mutation
Ya Su et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Clinical evaluation of [18F] JNJ-64326067, a novel candidate PET tracer for the detection of tau pathology in Alzheimer's disease
Mark E. Schmidt et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
18F-MK-6240 PET for early and late detection of neurofibrillary tangles
Tharick A. Pascoal et al.
BRAIN (2020)
Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy
Matthias Brendel et al.
JAMA NEUROLOGY (2020)
In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand F-18-MK-6240 in Humans from Alzheimer Disease Dementia to Young Controls
Tobey J. Betthauser et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Scan-Time Corrections for 80-100-min Standardized Uptake Volume Ratios to Measure the 18F-AV-1451 Tracer for Tau Imaging
Mark He et al.
IEEE TRANSACTIONS ON MEDICAL IMAGING (2019)
Discovery of N-(4-[18F]Fluoro-5-methylpyridin-2-yl)isoquinolin-6-amine (JNJ-64326067), a New Promising Tau Positron Emission Tomography Imaging Tracer
Frederik J. R. Rombouts et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Effect of Off-Target Binding on 18F-Flortaucipir Variability in Healthy Controls Across the Life Span
Suzanne L. Baker et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Progressive Tau Accumulation in Alzheimer Disease: 2-Year Follow-up Study
Hanna Cho et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Alzheimer's pathology targets distinct memory networks in the ageing brain
Anne Maass et al.
BRAIN (2019)
[18F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease
Sandra Sanabria Bohorquez et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies
Heiko Kroth et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia
Clifford R. Jack et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study
Bernard J. Hanseeuw et al.
JAMA NEUROLOGY (2019)
Longitudinal tau accumulation and atrophy in aging and alzheimer disease
Theresa M. Harrison et al.
ANNALS OF NEUROLOGY (2019)
Tau PET imaging in neurodegenerative tauopathies-still a challenge
Antoine Leuzy et al.
MOLECULAR PSYCHIATRY (2019)
Longitudinal tau-PET uptake and atrophy in atypical Alzheimer's disease
Irene Sintini et al.
NEUROIMAGE-CLINICAL (2019)
Off-Target 18F-AV-1451 Binding in the Basal Ganglia Correlates with Age-Related Iron Accumulation
Jae Yong Choi et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Characterization of 3 Novel Tau Radiopharmaceuticals, 11C-RO-963, 11C-RO-643, and 18F-RO-948, in Healthy Controls and in Alzheimer Subjects
Dean F. Wong et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Brain morphology, cognition, and beta-amyloid in older adults with superior memory performance
Theresa M. Harrison et al.
NEUROBIOLOGY OF AGING (2018)
Evaluation of F-18-RO-948 PET for Quantitative Assessment of Tau Accumulation in the Human Brain
Hiroto Kuwabara et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders
Rik Ossenkoppele et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging
Suzanne L. Baker et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
[18F]AV-1451 Tau Positron Emission Tomography in Progressive Supranuclear Palsy
Jennifer L. Whitwell et al.
MOVEMENT DISORDERS (2017)
Subcortical 18F-AV-1451 Binding Patterns in Progressive Supranuclear Palsy
Hanna Cho et al.
MOVEMENT DISORDERS (2017)
Increased Basal Ganglia Binding of 18F-AV-1451 in Patients With Progressive Supranuclear Palsy
Ruben Smith et al.
MOVEMENT DISORDERS (2017)
Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease
Anne Maass et al.
NEUROIMAGE (2017)
Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson's case
Marta Marquie et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Differential Incorporation of Tau Isoforms in Alzheimer's Disease
Marisol Espinoza et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data
Suzanne L. Baker et al.
DATA IN BRIEF (2017)
18F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study
Daniel R. Schonhaut et al.
ANNALS OF NEUROLOGY (2017)
[F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging
Marta Marquie et al.
ACTA NEUROPATHOLOGICA (2017)
Defining imaging biomarker cut points for brain aging and Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2017)
Tau Positron Emission Tomographic Imaging in Aging and Early Alzheimer Disease
Keith A. Johnson et al.
ANNALS OF NEUROLOGY (2016)
In Vivo Cortical Spreading Pattern of Tau and Amyloid in the Alzheimer Disease Spectrum
Hanna Cho et al.
ANNALS OF NEUROLOGY (2016)
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease
Rik Ossenkoppele et al.
BRAIN (2016)
Discovery of 6-(Fluoro-18F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([18F}-MK-6240): A Positron Emission Tomography (PET) Imaging Agent for Quantification of Neurofibrillary Tangles (NFTs)
Abbas M. Walji et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles
Eric D. Hostetler et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
PET Imaging of Tau Deposition in the Aging Human Brain
Michael Schoell et al.
NEURON (2016)
An autoradiographic evaluation of AV-1451 Tau PET in dementia
Val J. Lowe et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue
Marta Marquie et al.
ANNALS OF NEUROLOGY (2015)
Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation
Sylvia Villeneuve et al.
BRAIN (2015)
Radiosynthesis, Photoisomerization, Biodistribution, and Metabolite Analysis of 11C-PBB3 as a Clinically Useful PET Probe for Imaging of Tau Pathology
Hiroki Hashimoto et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807
David T. Chien et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Progressive supranuclear palsy: Pathology and genetics
Dennis W. Dickson et al.
BRAIN PATHOLOGY (2007)
分享论文
